Thursday, April 3, 2025
spot_img

KPN reports on progress of € 250m share buyback

KPN has repurchased 2,020,000 KPN ordinary shares in the period from 24 March to 28 March 2025. The shares were repurchased at an average price of € 3.84 per share for a total consideration of € 7.8m. These repurchases are part of the € 250m share buyback started on 25 February 2025 and reflect KPN’s commitment to structurally return additional capital to its shareholders.

The total number of ordinary shares repurchased to date is 9,454,964 for a total consideration of € 35.4m.

Transaction details of the share buyback are available on our website.

Formal disclosures:

Royal KPN N.V.
Head of IR: Matthijs van Leijenhorst
Inside information: Yes
Topic: KPN reports on progress of € 250m share buyback
31/03/2025
KPN-SBB

Attachment

  • KPN reports on progress of EUR 250m share buyback

Powered by SlickText.com

Hot this week

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES ...

Adoption of the decisions of AS PRFoods noteholders by written procedure

AS PRFoods (registry code 11560713, registered address at Pärnu...

Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam

Dear shareholder! The management board of AS Tallinna...

DNO Releases 2024 Annual Report and Accounts

Oslo, 3 April 2025 – DNO ASA, the Norwegian...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming”...

Topics

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES ...

Adoption of the decisions of AS PRFoods noteholders by written procedure

AS PRFoods (registry code 11560713, registered address at Pärnu...

Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam

Dear shareholder! The management board of AS Tallinna...

DNO Releases 2024 Annual Report and Accounts

Oslo, 3 April 2025 – DNO ASA, the Norwegian...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming”...

SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT

SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT...

dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

Press Release dsm-firmenich completes shareholding increase in Andre...
spot_img

Related Articles

Popular Categories

spot_img